1. Home
  2. OCSL vs EVMN Comparison

OCSL vs EVMN Comparison

Compare OCSL & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oaktree Specialty Lending Corporation

OCSL

Oaktree Specialty Lending Corporation

HOLD

Current Price

$13.12

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

EVMN

Evommune Inc.

N/A

Current Price

$27.21

Market Cap

892.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OCSL
EVMN
Founded
2007
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
892.4M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
OCSL
EVMN
Price
$13.12
$27.21
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$13.10
$43.88
AVG Volume (30 Days)
992.9K
265.1K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
12.59%
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.31
N/A
P/E Ratio
$211.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.63
$13.89
52 Week High
$14.90
$33.20

Technical Indicators

Market Signals
Indicator
OCSL
EVMN
Relative Strength Index (RSI) 76.29 57.92
Support Level $12.50 $21.14
Resistance Level $13.89 $28.82
Average True Range (ATR) 0.30 1.90
MACD 0.19 0.32
Stochastic Oscillator 88.89 79.51

Price Performance

Historical Comparison
OCSL
EVMN

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: